CAGLAR, IlknurDEVRIM, IlkerOzdemir, HalilSahbudak, ZumrutSonmez, GulsumBuyukcam, AyseGULHAN, BelginKARA, AhuAygun, Deniz F.BAYRAM, NuriCelebi, SolmazCETIN, BenhurNepesov, MerveYilmaz, Ayse T.KEPENEKLI, EdaCiftdogan, Dilek YilmazAcar, Manolya K.Yayla, Burcu CuraOkumus, CananEcevit, ZaferHATIPOGLU, NevinKuyucu, NecdetKOSKER, MuhammedSen, SemraKARBUZ, AdemSUTCU, MuratDURAMAZ, Burcu BursalOzen, MetehanCiftci, ErginAlabaz, DeryaKurugol, ZaferKara, AtesKANIK, SalihaKilic, OmerOncel, SelimSomer, AyperTapisiz, AnilBelet, NursenAKCAN, Ozge MetinTurel, OzdenOZKAYA, AslinurTezer, HasanCengiz, Ali BulentInce, ErdalCamcioglu, YildizKocabas, EmineArisoy, Emin S.Salman, Nuran2019-10-052019-10-052018-12-01CAGLAR I., DEVRIM I., Ozdemir H., Sahbudak Z., Sonmez G., Buyukcam A., GULHAN B., KARA A., Aygun D. F. , BAYRAM N., et al., -Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence survey-, JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, cilt.15, ss.232-238, 2018https://hdl.handle.net/20.500.12645/6752Objectives: The aim of this point prevalence survey was to evaluate the consumption, indications and strategies of antifungal therapy in the paediatric population in Turkey.enAntifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence surveyArticle30121343